ReviewGut microbes2026
Feeding microbes to feed the Gut: inulin reprograms intestinal epithelial metabolism and proliferation through HIF1α.
Review in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Indigestible dietary fibers shape intestinal mucosal physiology, yet the mechanisms linking fiber-derived microbial activity to epithelial remodeling remain incompletely understood. In their recent study, Ribeiro Castro et al. revealed that the prebiotic inulin induces reprogramming of intestinal epithelial metabolism and proliferation through microbiota-dependent hypoxia and epithelial HIF1α activation. In this commentary, we discuss their findings and highlight the emerging concept that microbial fermentation and oxygen concentrations act as structured physiological signals that guide intestinal epithelial differentiation and crypt-villus dynamics. We further explore how these findings intersect with prior work on SCFA metabolism, butyrate-mediated ISC inhibition, and fructose-driven epithelial growth, and we discuss open questions regarding downstream HIF1α programs, niche accessibility, and immune‒epithelial crosstalk. Understanding how HIF1α calibrates this balance will be essential for safely leveraging prebiotics and microbiome-targeted interventions that promote mucosal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.